Prevention of acute and delayed chemotherapy-induced nausea and vomiting in pediatric cancer patients: A clinical practice guideline.
Pediatr Blood Cancer
; 69(12): e30001, 2022 12.
Article
em En
| MEDLINE
| ID: mdl-36221901
ABSTRACT
This clinical practice guideline provides recommendations for preventing acute and delayed phase chemotherapy-induced nausea and vomiting (CINV) in pediatric patients. The recommendations are based on two systematic reviews of randomized controlled trials evaluating interventions to prevent (1) acute phase CINV and (2) delayed phase CINV. Recommendations for acute phase and delayed phase CINV prophylaxis are made for patients receiving chemotherapy of varying emetogenicity, as well as for patients not able to receive dexamethasone or a neurokinin-1 receptor antagonist. Evidence gaps, including antiemetic safety and optimal dosing, were identified.
Palavras-chave
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Antieméticos
/
Neoplasias
/
Antineoplásicos
Tipo de estudo:
Clinical_trials
/
Guideline
/
Systematic_reviews
Limite:
Child
/
Humans
Idioma:
En
Ano de publicação:
2022
Tipo de documento:
Article